BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34800515)

  • 1. Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis.
    Mafra RP; Sabino VG; Rolim LSA; de Carvalho CHP; Nonaka CFW; Barboza CAG; de Souza LB; Pinto LP
    Exp Mol Pathol; 2022 Feb; 124():104722. PubMed ID: 34800515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
    Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
    J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck.
    Yasuda T; Sakata Y; Kitamura K; Morita M; Ishida T
    Head Neck; 1997 Oct; 19(7):611-6. PubMed ID: 9323150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
    Liu L; Wang X; Ge W
    Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
    Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
    J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
    Zhao LL
    J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production.
    Kai K; Moriyama M; Haque ASMR; Hattori T; Chinju A; Hu C; Kubota K; Miyahara Y; Kakizoe-Ishiguro N; Kawano S; Nakamura S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.
    Pasini FS; Brentani MM; Kowalski LP; Federico MH
    Head Neck; 2001 Sep; 23(9):725-32. PubMed ID: 11505481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNAIL1 is involved in the control of the epithelial-mesenchymal transition in oral tongue squamous cell carcinoma.
    de Morais EF; Morais HGF; de França GM; Téo FH; Galvão HC; Salo T; Coletta RD; Freitas RA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Apr; 135(4):530-538. PubMed ID: 36918320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of HSP27 does not seem to influence the prognosis of oral tongue squamous cell carcinoma.
    Torres OKMR; Silva LABD; Freitas RA; Silveira ÉJDD; Miguel MCDC
    Braz Dent J; 2023; 34(5):125-133. PubMed ID: 38133467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.
    Liu TJ; Guo JL; Wang HK; Xu X
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1035-1043. PubMed ID: 29509252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
    Chen YH; Chen CH; Chien CY; Su YY; Luo SD; Li SH
    BMC Cancer; 2021 Sep; 21(1):979. PubMed ID: 34465286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocytes and head and neck squamous cell carcinoma cells regulate urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in fibroblasts.
    Hakelius M; Koskela A; Ivarsson M; Grenman R; Rubin K; Gerdin B; Nowinski D
    Anticancer Res; 2013 Aug; 33(8):3113-8. PubMed ID: 23898067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
    Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
    Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
    Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma.
    Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A
    Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway.
    Wang LP; Chen SW; Zhuang SM; Li H; Song M
    Pathol Oncol Res; 2013 Jul; 19(3):461-74. PubMed ID: 23519607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
    Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
    J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.